IFNA1 and COVID-19: evaluated serum IFN-α levels using a single molecular array in 64 critically ill patients with COVID-19 at a relatively early phase of SARS-CoV-2 infection (serum collected on admission) and compared the IFN-α levels between survivors and non-survivors (33).